Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 4/20 | 0.40 |
| ▸ | LMNA | P02545 | 3/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | HBB | P68871 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.32 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.32 |
| ▸ | SLC22A3 | O75751 | 1/20 | 0.32 |
| ▸ | ESR1 | P03372 | 1/20 | 0.32 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.32 |
| ▸ | HTR1A | P08908 | 1/20 | 0.32 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.32 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.32 |
| ▸ | DRD2 | P14416 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6756617 | 0.97 | MEN1 (0.55) | MEN1KMT2AMAPTTSHRLMNA | |
| SCHEMBL14355539 | 0.89 | MEN1 (0.48) | MEN1KMT2AMAPTTSHRLMNA | |
| SCHEMBL12860961 | 0.85 | — | — | |
| Hydrochloric Acid SCHEMBL10746384 | 0.83 | MEN1 (0.48) | MEN1KMT2AMAPTTSHRLMNA | |
| SCHEMBL9004138 | 0.79 | MEN1 (0.44) | MEN1KMT2AMAPTTSHRLMNA | |
| SCHEMBL2990827 | 0.73 | MEN1 (1.00) | MEN1KMT2AMAPTTSHRLMNA | |
| SCHEMBL226273 | 0.73 | MEN1 (1.00) | MEN1KMT2AMAPTTSHRLMNA | |
| SCHEMBL1252790 | 0.73 | MEN1 (0.43) | MEN1KMT2AMAPTTSHRLMNA | |
| SCHEMBL5908848 | 0.71 | MEN1 (0.42) | MEN1KMT2AMAPTTSHRLMNA | |
| SCHEMBL10716586 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4692074-A1 | CRBN LIGAND, PREPARATION METHOD THEREFOR, AND APPLICATION | Shenzhen Zhongge Biological Technology Co., Ltd. (CN) | 2026-02-11 | — | — | EP | claimed |
| EP-4644384-A1 | CYP11A1 INHIBITOR COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF | Shanghai Lichun Biotech Co., Ltd. (CN) | 2025-11-05 | — | — | EP | claimed |
| CN-113563245-B | Substituted pyrrolidines and their use in medicine | 广东东阳光药业股份有限公司 | 2024-10-15 | — | — | CN | claimed |
| WO-2024208331-A1 | CRBN LIGAND, PREPARATION METHOD THEREFOR, AND APPLICATION | 深圳众格生物科技有限公司 | 2024-10-10 | — | — | WO | claimed |
| WO-2024146383-A1 | CYP11A1 INHIBITOR COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 上海闻耐医药科技有限公司 | 2024-07-11 | — | — | WO | claimed |
| CN-118307519-A | CYP11A1 inhibitor compound, preparation method and application thereof | 上海闻耐医药科技有限公司 | 2024-07-09 | — | — | CN | claimed |
| CN-112390904-B | Polyethylene containing polar functional groups and preparation method thereof | 中国科学院上海有机化学研究所 | 2023-05-09 | — | — | CN | claimed |
| US-11447470-B2 | Pyrimidinone-containing compound, preparation method thereof, pharmaceutical composition and application thereof | YUNNAN UNIVERSITY (CN) | 2022-09-20 | — | — | US | claimed |
| CN-114667290-A | Yttrium or lanthanide metal precursor compounds, film-forming compositions containing the same, and methods of forming yttrium or lanthanide metal-containing films using the same | UP化学株式会社 | 2022-06-24 | — | — | CN | claimed |
| WO-2022022364-A1 | PYRROLIDINE INTEGRIN MODULATOR AND USE THEREOF | 清药同创(北京)药物研发中心有限公司 | 2022-02-03 | — | — | WO | claimed |
| EP-4692074-A1 | CRBN LIGAND, PREPARATION METHOD THEREFOR, AND APPLICATION | Shenzhen Zhongge Biological Technology Co., Ltd. (CN) | 2026-02-11 | — | — | EP | disclosed |
| EP-4644384-A1 | CYP11A1 INHIBITOR COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF | Shanghai Lichun Biotech Co., Ltd. (CN) | 2025-11-05 | — | — | EP | disclosed |
| WO-2025215579-A1 | NOVEL NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS | PFIZER INC. (US) | 2025-10-16 | — | — | WO | disclosed |
| US-12378265-B2 | Process for preparing organotin compounds | ENTEGRIS, INC. (US) | 2025-08-05 | — | — | US | disclosed |
| CN-113563245-B | Substituted pyrrolidines and their use in medicine | 广东东阳光药业股份有限公司 | 2024-10-15 | — | — | CN | disclosed |
| US-6197791-B1 | ANTIARTHRITIC AGENTS; WOUND HEALING AGENTS; ANTITUMOR AGENTS | AMERICAN CYANAMID COMPANY | 2001-03-06 | — | — | US | disclosed |
| US-6172057-B1 | ANTIINFLAMMATORY AGENTS; ANTIARTHRITIC AGENTS; ANTITUMOR AGENTS | AMERICAN CYANAMID COMPANY | 2001-01-09 | — | — | US | disclosed |
| EP-0970046-A1 | N-HYDROXY-2-(ALKYL, ARYL, OR HETEROARYL SULFANYL, SULFINYL OR SULFONYL)-3-SUBSTITUTED ALKYL, ARYL OR HETEROARYLAMIDES AS MATRIX METALLOPROTEINASE INHIBITORS | American Cyanamid Company (US) | 2000-01-12 | — | — | EP | disclosed |
| WO-1998038163-A1 | N-HYDROXY-2-(ALKYL, ARYL, OR HETEROARYL SULFANYL, SULFINYL OR SULFONYL)-3-SUBSTITUTED ALKYL, ARYL OR HETEROARYLAMIDES AS MATRIX METALLOPROTEINASE INHIBITORS | AMERICAN CYANAMID COMPANY (US) | 1998-09-03 | — | — | WO | disclosed |
| US-5051363-A | Decreasing the toxicity of nitrogen mustard gas | UNIVERSITY OF PENNSYLVANIA (US) | 1991-09-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11447470-B2 | Pyrimidinone-containing compound, preparation method thereof, pharmaceutical composition and application thereof | TYMP, DPYD, DHPS | MEN1 2250/4885KMT2A 3182/4885MAPT 2435/4885 |
| US-12378265-B2 | Process for preparing organotin compounds | ETV6, TPMT, TTN | MEN1 296/4885KMT2A 346/4885MAPT 80/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.